AI Science Tracker

AlphaCD maps experimentally measured catalytic properties across cytidine deaminases and supports a high-fidelity editor

Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences · 18 Aug 2025 · biology

Discovery

AlphaCD maps experimentally measured catalytic properties across cytidine deaminases and supports a high-fidelity editor

The researchers measured catalytic efficiency, editing windows, motif preferences and off-target activity for 1,100 APOBEC-like cytidine deaminases fused to nCas9 in HEK293T cells, then trained AlphaCD to predict these properties. They applied it to 21,335 UniProt deaminases and experimentally checked a 28-protein subsample. As an application, the team used AlphaCD to identify a high-efficiency deaminase and alanine scanning to produce the E100A variant, which retained editing activity while reducing off-target activity; cell experiments tested editing at endogenous loci and a PCSK9 splice site.

Technology: AlphaCD, a machine-learning model trained on sequence, predicted structure and related protein features

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The researchers measured catalytic efficiency, editing windows, motif preferences and off-target activity for 1,100 APOBEC-like cytidine deaminases fused to nCas9 in HEK293T cells, then trained AlphaCD to predict these properties.
  • Still unknown: The large functional dataset was measured in HEK293T reporter assays. The 21,335-protein landscape is model-predicted, with a 28-protein validation subsample. The engineered E100A editor was tested in cells; these experiments do not establish therapeutic safety, in-vivo efficacy or clinical benefit. This is distinct from the earlier AlphaFold2 structural-clustering papers: the named discovery and assay here concern the 1,100-enzyme dataset, AlphaCD predictions and A0A2R2Z4E4 E100A variant, not CD0208^P52A or the 2023 DddA-like clade findings.
  • AI role: AlphaCD learned experimentally measured activity, editing-window, motif and off-target properties across 1,100 deaminases, predicted properties for 21,335 database sequences, and was applied to select a high-efficiency candidate for subsequent alanine-scanning engineering. The authors report the model's predictions validated on 28 sampled deaminases; the E100A mutation itself was experimentally produced by alanine scanning, not generated by the model.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/40825882/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 80 of works of the same type, year and subfield (OpenAlex work metrics, 7 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.